These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31017389)

  • 1. Ultrasensitive and Reversible Nanoplatform of Urinary Exosomes for Prostate Cancer Diagnosis.
    Li P; Yu X; Han W; Kong Y; Bao W; Zhang J; Zhang W; Gu Y
    ACS Sens; 2019 May; 4(5):1433-1441. PubMed ID: 31017389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer biomarker profiles in urinary sediments and exosomes.
    Dijkstra S; Birker IL; Smit FP; Leyten GH; de Reijke TM; van Oort IM; Mulders PF; Jannink SA; Schalken JA
    J Urol; 2014 Apr; 191(4):1132-8. PubMed ID: 24211598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and specific detection nanoplatform of serum exosomes for prostate cancer diagnosis.
    Li Q; Wang Y; Ling L; Qiao L; Chen H; Ding C; Yu S
    Mikrochim Acta; 2021 Aug; 188(8):283. PubMed ID: 34341883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.
    Duijvesz D; Versluis CY; van der Fels CA; Vredenbregt-van den Berg MS; Leivo J; Peltola MT; Bangma CH; Pettersson KS; Jenster G
    Int J Cancer; 2015 Dec; 137(12):2869-78. PubMed ID: 26139298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer.
    Nilsson J; Skog J; Nordstrand A; Baranov V; Mincheva-Nilsson L; Breakefield XO; Widmark A
    Br J Cancer; 2009 May; 100(10):1603-7. PubMed ID: 19401683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
    Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer.
    Lee J; Kwon MH; Kim JA; Rhee WJ
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S52-S63. PubMed ID: 30033809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary biomarkers of prostate cancer.
    Fujita K; Nonomura N
    Int J Urol; 2018 Sep; 25(9):770-779. PubMed ID: 30129068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.
    Hendriks RJ; Dijkstra S; Jannink SA; Steffens MG; van Oort IM; Mulders PF; Schalken JA
    Clin Chem Lab Med; 2016 Mar; 54(3):483-92. PubMed ID: 26630694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
    Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can urinary exosomes act as treatment response markers in prostate cancer?
    Mitchell PJ; Welton J; Staffurth J; Court J; Mason MD; Tabi Z; Clayton A
    J Transl Med; 2009 Jan; 7():4. PubMed ID: 19138409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory-Based Techniques: Protocol for a Case-Control Study.
    Li G; Tholance Y; Mallouk N; Waeckel L; Flandrin P; Bali B; Badet L; Cornillon P
    JMIR Res Protoc; 2024 Sep; 13():e63551. PubMed ID: 39024018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel peptide-templated AgNPs nanoprobe for theranostics of prostate cancer.
    Cheng W; Sun Y; Zhao G; Khan A; Zhang J; Zhang Z; Yi Y; Kong D; Li J
    Biosens Bioelectron; 2023 Mar; 223():114978. PubMed ID: 36586149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
    Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.
    Motamedinia P; Scott AN; Bate KL; Sadeghi N; Salazar G; Shapiro E; Ahn J; Lipsky M; Lin J; Hruby GW; Badani KK; Petrylak DP; Benson MC; Donovan MJ; Comper WD; McKiernan JM; Russo LM
    PLoS One; 2016; 11(5):e0154507. PubMed ID: 27144529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.